Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Share-based Compensation (2024 - 2026)

Indivior Pharmaceuticals has reported Share-based Compensation over the past 3 years, most recently at $9.0 million for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 50.0% year-over-year to $9.0 million; the TTM value through Mar 2026 reached $29.0 million, up 20.83%, while the annual FY2025 figure was $26.0 million, 8.33% up from the prior year.
  • Share-based Compensation for Q1 2026 was $9.0 million at Indivior Pharmaceuticals, up from $5.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $9.0 million in Q1 2026 and troughed at $5.0 million in Q4 2025.
  • A 3-year average of $6.6 million and a median of $6.0 million in 2024 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: fell 16.67% in 2025 and later skyrocketed 50.0% in 2026.
  • Year by year, Share-based Compensation stood at $6.0 million in 2024, then fell by 16.67% to $5.0 million in 2025, then soared by 80.0% to $9.0 million in 2026.
  • Business Quant data shows Share-based Compensation for INDV at $9.0 million in Q1 2026, $5.0 million in Q4 2025, and $7.0 million in Q3 2025.